These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11157143)

  • 1. The effects of treatment with interleukin-1 receptor antagonist on the inflamed synovial membrane in rheumatoid arthritis.
    Cunnane G; Madigan A; Murphy E; FitzGerald O; Bresnihan B
    Rheumatology (Oxford); 2001 Jan; 40(1):62-9. PubMed ID: 11157143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.
    Bresnihan B; Alvaro-Gracia JM; Cobby M; Doherty M; Domljan Z; Emery P; Nuki G; Pavelka K; Rau R; Rozman B; Watt I; Williams B; Aitchison R; McCabe D; Musikic P
    Arthritis Rheum; 1998 Dec; 41(12):2196-204. PubMed ID: 9870876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prospect of treating rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.
    Bresnihan B
    BioDrugs; 2001; 15(2):87-97. PubMed ID: 11437678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores.
    Jiang Y; Genant HK; Watt I; Cobby M; Bresnihan B; Aitchison R; McCabe D
    Arthritis Rheum; 2000 May; 43(5):1001-9. PubMed ID: 10817552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiolabelled interleukin-1 receptor antagonist for detection of synovitis in patients with rheumatoid arthritis.
    Barrera P; van der Laken CJ; Boerman OC; Oyen WJ; van de Ven MT; van Lent PL; van de Putte LB; Corstens FH
    Rheumatology (Oxford); 2000 Aug; 39(8):870-4. PubMed ID: 10952741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis.
    Bresnihan B
    Semin Arthritis Rheum; 2001 Apr; 30(5 Suppl 2):17-20. PubMed ID: 11357167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. The IL-1Ra Arthritis Study Group.
    Campion GV; Lebsack ME; Lookabaugh J; Gordon G; Catalano M
    Arthritis Rheum; 1996 Jul; 39(7):1092-101. PubMed ID: 8670316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifibrotic action of interleukin-1 receptor antagonist in lapine monoarticular arthritis.
    Lewthwaite J; Blake S; Thompson RC; Hardingham TE; Henderson B
    Ann Rheum Dis; 1995 Jul; 54(7):591-6. PubMed ID: 7668904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1, interleukin-1 receptor antagonist and macrophage populations in rheumatoid arthritis synovial membrane.
    Cauli A; Yanni G; Panayi GS
    Br J Rheumatol; 1997 Sep; 36(9):935-40. PubMed ID: 9376987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis.
    Deleuran BW; Chu CQ; Field M; Brennan FM; Katsikis P; Feldmann M; Maini RN
    Br J Rheumatol; 1992 Dec; 31(12):801-9. PubMed ID: 1458286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of recombinant human interleukin 1 receptor antagonist on the induction phase of antigen induced arthritis in the rabbit.
    Lewthwaite J; Blake SM; Hardingham TE; Warden PJ; Henderson B
    J Rheumatol; 1994 Mar; 21(3):467-72. PubMed ID: 8006890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 receptor antagonist production in cultured synovial cells from patients with rheumatoid arthritis and osteoarthritis.
    Fujikawa Y; Shingu M; Torisu T; Masumi S
    Ann Rheum Dis; 1995 Apr; 54(4):318-20. PubMed ID: 7763113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased IL-1 receptor antagonist (IL-1ra) production and decreased IL-1 beta/IL-1ra ratio in mononuclear cells from rheumatoid arthritis patients.
    Shingu M; Fujikawa Y; Wada T; Nonaka S; Nobunaga M
    Br J Rheumatol; 1995 Jan; 34(1):24-30. PubMed ID: 7881833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of rheumatoid arthritis is associated with a reduction in synovial membrane cytokines and cell adhesion molecule expression.
    Smith MD; Slavotinek J; Au V; Weedon H; Parker A; Coleman M; Roberts-Thomson PJ; Ahern MJ
    Rheumatology (Oxford); 2001 Sep; 40(9):965-77. PubMed ID: 11561106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in cytokine and cell adhesion molecule staining in arthroscopic synovial biopsies: quantification using color video image analysis.
    Youssef PP; Triantafillou S; Parker A; Coleman M; Roberts-Thomson PJ; Ahern MJ; Smith MD
    J Rheumatol; 1997 Dec; 24(12):2291-8. PubMed ID: 9415630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy].
    Fiocco U; Vezzù M; Cozzi L; Todesco S
    Reumatismo; 2004; 56(1 Suppl 1):62-73. PubMed ID: 15201942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis.
    Tang WW; Feng L; Vannice JL; Wilson CB
    J Clin Invest; 1994 Jan; 93(1):273-9. PubMed ID: 7904269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anakinra: a review of its use in the management of rheumatoid arthritis.
    Waugh J; Perry CM
    BioDrugs; 2005; 19(3):189-202. PubMed ID: 15984903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial.
    Fisher CJ; Slotman GJ; Opal SM; Pribble JP; Bone RC; Emmanuel G; Ng D; Bloedow DC; Catalano MA;
    Crit Care Med; 1994 Jan; 22(1):12-21. PubMed ID: 8124953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.